NFKB1 and early-onset autosomal dominant Alzheimer disease: Studies have reported that Agathobacter and its metabolic product butyrate can alleviate neuroinflammation induced by Alzheimer’s disease (AD) by regulating the NF-κB signaling pathway (Lv et al., 2024).